pSivida Corp. Company Profile (NASDAQ:PSDV)

About pSivida Corp. (PSDV)

pSivida Corp. logopSivida Corp. develops drug delivery products primarily for the treatment of chronic eye diseases. The Company operates through the biotechnology sector segment. The Company has developed three products for treatment of back-of-the-eye diseases, which include Medidur for posterior segment uveitis, its lead product candidate that is in pivotal Phase III clinical trials; ILUVIEN for diabetic macular edema (DME), its lead licensed product that is sold in the United States and European Union (EU) countries, and Retisert. Medidur is designed to treat chronic non-infectious uveitis affecting the posterior segment of the eye (posterior segment uveitis). ILUVIEN is an injectable micro-insert that provides treatment of DME from a single injection. Retisert is an implant that provides treatment of posterior segment uveitis. Its product development program is focused on utilizing its two technology platforms, Durasert and Tethadur, to deliver drugs and biologics to treat chronic diseases.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drugs - Generic
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: PSDV
  • CUSIP: N/A
Key Metrics:
  • Previous Close: $1.70
  • 50 Day Moving Average: $1.73
  • 200 Day Moving Average: $2.13
  • 52-Week Range: $1.50 - $4.25
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -7.64
  • P/E Growth: 0.00
  • Market Cap: $57.42M
  • Outstanding Shares: 34,176,000
  • Beta: 1.74
Profitability:
  • Net Margins: -271.33%
  • Return on Equity: -97.39%
  • Return on Assets: -66.37%
Debt:
  • Current Ratio: 3.77%
  • Quick Ratio: 3.77%

Analyst Ratings

Consensus Ratings for pSivida Corp. (NASDAQ:PSDV) (?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $7.00 (316.67% upside)

Analysts' Ratings History for pSivida Corp. (NASDAQ:PSDV)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
12/6/2016FBR & CoReiterated RatingOutperform$7.00N/AView Rating Details
12/29/2015Ladenburg Thalmann Financial ServicesReiterated RatingBuyN/AView Rating Details
12/17/2015Northland SecuritiesReiterated RatingBuyN/AView Rating Details
7/7/2015MLV & Co.Reiterated RatingBuy$6.50N/AView Rating Details
(Data available from 3/23/2015 forward)

Earnings

Earnings History for pSivida Corp. (NASDAQ:PSDV)
Earnings by Quarter for pSivida Corp. (NASDAQ:PSDV)
Earnings History by Quarter for pSivida Corp. (NASDAQ:PSDV)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/3/2017        
11/7/2016Q1($0.19)($0.21)ViewListenView Earnings Details
9/12/2016Q4($0.13)($0.19)ViewListenView Earnings Details
5/5/2016Q3($0.20)($0.15)ViewN/AView Earnings Details
11/5/2015Q116($0.15)($0.17)ViewN/AView Earnings Details
9/9/2015Q415($0.14)($0.17)$409.00 millionViewN/AView Earnings Details
5/8/2015Q315($0.13)($0.17)ViewN/AView Earnings Details
2/5/2015($0.13)($0.14)ViewN/AView Earnings Details
11/7/2014Q3 14($0.12)$0.67$25.30 millionViewN/AView Earnings Details
9/9/2014Q414($0.15)($0.15)ViewN/AView Earnings Details
5/13/2014Q314($0.15)($0.03)$0.55 million$2.00 millionViewN/AView Earnings Details
2/7/2014Q214($0.13)($0.13)$430.00 million$0.59 millionViewN/AView Earnings Details
11/12/2013Q1($0.14)ViewListenView Earnings Details
9/25/2013Q413($0.12)($0.17)$0.65 million$0.49 millionViewN/AView Earnings Details
2/6/2013Q2 2013($0.11)$0.63 million$0.59 millionViewListenView Earnings Details
11/8/2012Q113($0.10)($0.11)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for pSivida Corp. (NASDAQ:PSDV)
Current Year EPS Consensus Estimate: $-0.52 EPS
Next Year EPS Consensus Estimate: $-0.22 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q4 20161($0.10)($0.10)($0.10)
Q2 20171($0.19)($0.19)($0.19)
Q3 20171($0.17)($0.17)($0.17)
Q4 20171($0.15)($0.15)($0.15)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for pSivida Corp. (NASDAQ:PSDV)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for pSivida Corp. (NASDAQ:PSDV)
Insider Ownership Percentage: 4.49%
Institutional Ownership Percentage: 29.03%
Insider Trades by Quarter for pSivida Corp. (NASDAQ:PSDV)
Institutional Ownership by Quarter for pSivida Corp. (NASDAQ:PSDV)
Insider Trades by Quarter for pSivida Corp. (NASDAQ:PSDV)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/4/2016Leonard S. RossVPSell5,000$4.70$23,500.00View SEC Filing  
12/22/2015Leonard S. RossVPSell33,950$5.39$182,990.50View SEC Filing  
12/22/2015Paul AshtonCEOSell120,000$5.39$646,800.00View SEC Filing  
10/1/2014Paul AshtonCEOSell10,000$4.27$42,700.00View SEC Filing  
9/2/2014Paul AshtonCEOSell10,000$4.78$47,800.00View SEC Filing  
8/1/2014Paul AshtonCEOSell10,000$4.37$43,700.00View SEC Filing  
7/1/2014Paul AshtonCEOSell10,000$4.32$43,200.00View SEC Filing  
6/19/2014Paul AshtonCEOSell7,000$4.00$28,000.00View SEC Filing  
6/17/2014Lori FreedmanVPSell7,900$4.00$31,600.00View SEC Filing  
6/17/2014Paul AshtonCEOSell7,700$4.00$30,800.00View SEC Filing  
6/13/2014Lori FreedmanVPSell11,700$4.02$47,034.00View SEC Filing  
6/13/2014Paul AshtonCEOSell11,800$4.02$47,436.00View SEC Filing  
10/1/2012Paul HopperDirectorBuy10,000$1.68$16,800.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for pSivida Corp. (NASDAQ:PSDV)
Latest Headlines for pSivida Corp. (NASDAQ:PSDV)
Source:
DateHeadline
streetinsider.com logopSivida (PSDV) Says Abstract on Treatment of Posterior Segment Uveitis Accepted for Presentation at ARVO - StreetInsider.com (NASDAQ:PSDV)
www.streetinsider.com - March 16 at 8:25 AM
streetinsider.com logopSivida (PSDV) Says Abstract on Treatment of Posterior Segment Uveitis Accepted for Presentation at ARVO (NASDAQ:PSDV)
www.streetinsider.com - March 15 at 9:14 AM
finance.yahoo.com logoAbstract on pSivida's Treatment of Posterior Segment Uveitis Accepted for Presentation at the 2017 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting (NASDAQ:PSDV)
finance.yahoo.com - March 15 at 9:14 AM
biz.yahoo.com logoPSIVIDA CORP. Files SEC form 8-K, Other Events (NASDAQ:PSDV)
biz.yahoo.com - March 6 at 6:42 PM
seekingalpha.com logopSivida (PSDV) Presents At 19th Annual BIO CEO & Investor Conference - Slideshow (NASDAQ:PSDV)
seekingalpha.com - February 16 at 6:57 PM
seekingalpha.com logopSivida (PSDV) Presents At 19th Annual BIO CEO & Investor Conference - Slideshow (NASDAQ:PSDV)
seekingalpha.com - February 16 at 6:57 PM
finance.yahoo.com logoPSIVIDA CORP. Financials (NASDAQ:PSDV)
finance.yahoo.com - February 16 at 6:57 PM
finance.yahoo.com logoPSIVIDA CORP. Financials (NASDAQ:PSDV)
finance.yahoo.com - February 16 at 6:57 PM
globenewswire.com logopSivida to Present at the 2017 BIO CEO & Investor Conference - GlobeNewswire (press release) (NASDAQ:PSDV)
globenewswire.com - February 11 at 2:32 AM
finance.yahoo.com logopSivida to Present at the 2017 BIO CEO & Investor Conference (NASDAQ:PSDV)
finance.yahoo.com - February 10 at 9:30 PM
biz.yahoo.com logoPSIVIDA CORP. Files SEC form 10-Q, Quarterly Report (NASDAQ:PSDV)
biz.yahoo.com - February 9 at 10:02 PM
biz.yahoo.com logoPSIVIDA CORP. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (NASDAQ:PSDV)
us.rd.yahoo.com - February 9 at 2:15 AM
globenewswire.com logopSivida Corp. Reports Fiscal 2017 Second Quarter and First Half Results - GlobeNewswire (press release) (NASDAQ:PSDV)
www.globenewswire.com - February 8 at 9:12 PM
finance.yahoo.com logoEdited Transcript of PSDV earnings conference call or presentation 7-Feb-17 9:30pm GMT (NASDAQ:PSDV)
finance.yahoo.com - February 8 at 9:12 PM
biz.yahoo.com logoPSIVIDA CORP. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits (NASDAQ:PSDV)
biz.yahoo.com - February 8 at 9:12 PM
us.rd.yahoo.com logopSivida Corp. Reports Fiscal 2017 Second Quarter and First Half Results (NASDAQ:PSDV)
us.rd.yahoo.com - February 7 at 9:59 PM
biz.yahoo.com logoQ2 2017 pSivida Corp Earnings Release - After Market Close (NASDAQ:PSDV)
biz.yahoo.com - February 7 at 8:43 AM
feeds.benzinga.com logopSivida Corp. Announces Second Quarter Fiscal Year 2017 Financial Results Release Date and Conference Call Information (NASDAQ:PSDV)
feeds.benzinga.com - January 25 at 8:49 AM

Social

Frequently Asked Questions for pSivida Corp. (NASDAQ:PSDV)

What is pSivida Corp.'s stock symbol?

pSivida Corp. trades on the NASDAQ under the ticker symbol "PSDV."

How were pSivida Corp.'s earnings last quarter?

pSivida Corp. (NASDAQ:PSDV) issued its earnings results on Monday, September, 12th. The company reported ($0.19) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.13) by $0.06. pSivida Corp. had a negative return on equity of 97.39% and a negative net margin of 271.33%.

When will pSivida Corp. make its next earnings announcement?

pSivida Corp. is scheduled to release their next quarterly earnings announcement on Wednesday, May, 3rd 2017.

Where is pSivida Corp.'s stock going? Where will pSivida Corp.'s stock price be in 2017?

1 equities research analysts have issued 12 month price targets for pSivida Corp.'s stock. Their predictions range from $7.00 to $7.00. On average, they anticipate pSivida Corp.'s share price to reach $7.00 in the next year.

Who owns pSivida Corp. stock?

pSivida Corp.'s stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Perceptive Advisors LLC (6.67%), Deerfield Management Co. (4.37%), Renaissance Technologies LLC (2.65%), North Run Capital LP (2.63%) and Bard Associates Inc. (0.30%). Company insiders that own pSivida Corp. stock include Leonard S Ross and Paul Ashton.

Who sold pSivida Corp. stock? Who is selling pSivida Corp. stock?

pSivida Corp.'s stock was sold by a variety of institutional investors in the last quarter, including North Run Capital LP and Bard Associates Inc..

Who bought pSivida Corp. stock? Who is buying pSivida Corp. stock?

pSivida Corp.'s stock was bought by a variety of institutional investors in the last quarter, including Perceptive Advisors LLC and Renaissance Technologies LLC.

How do I buy pSivida Corp. stock?

Shares of pSivida Corp. can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of pSivida Corp. stock cost?

One share of pSivida Corp. stock can currently be purchased for approximately $1.68.

pSivida Corp. (PSDV) Chart for Thursday, March, 23, 2017

This page was last updated on 3/23/2017 by MarketBeat.com Staff